SCHEMBL6412967

SCHEMBL6412967

CCN(C(=O)c1ccc(O)c(NC(=O)C(=O)Nc2cc(Cl)cc(Cl)c2O)c1)N(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.41
HSP90AB1 P08238 2/20 0.41
HSPA5 P11021 1/20 0.38
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
HPGD P15428 1/20 0.37
POLB P06746 1/20 0.37
KCNMA1 Q12791 7/20 0.37
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 2/20 0.34
USP2 O75604 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
HDAC1 Q13547 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6409044 0.79 KMT2A (0.50) HSPA5MEN1KMT2AHPGDPOLB
SCHEMBL6414640 0.79 ACLY (0.49) HSPA5MEN1KMT2APOLBKCNMA1
SCHEMBL6412962 0.77 KMT2A (0.47) HSPA5MEN1KMT2AHPGDKCNMA1
SCHEMBL6408135 0.77 KCNMA1 (0.55) HSPA5MEN1KMT2AHPGDPOLB
SCHEMBL6414166 0.76 CHRM3 (0.35) HSP90AA1HSP90AB1HSPA5MEN1KMT2A
SCHEMBL6409644 0.76 HPGD (0.46) MEN1KMT2AHPGDPOLBNPC1
SCHEMBL6407658 0.75 CA1 (0.48) HSPA5POLBKCNMA1MAPTMAPK1
SCHEMBL6408434 0.74 MEN1 (0.50) MEN1KMT2AHPGDKCNMA1NPC1
SCHEMBL6407747 0.74 ALDH1A1 (0.56) HSPA5MEN1KMT2APOLBNPC1
SCHEMBL6410312 0.72 KCNMA1 (0.52) HSPA5POLBKCNMA1STAT3ACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124667-A1 Oxamide inhibitors of plasminogen activator inhibitor-1 CEREP SA (FR) 2005-06-09 US claimed
US-20050124667-A1 Oxamide inhibitors of plasminogen activator inhibitor-1 CEREP SA (FR) 2005-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124667-A1 Oxamide inhibitors of plasminogen activator inhibitor-1 SERPINE1, SERPINC1, SERPINB1 HSP90AA1 3508/4885HSP90AB1 3347/4885HSPA5 4261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.